Pneumologie meets Kardiologie: Kardiale Sarkoidose

Zeitschrift für Pneumologie - Tập 20 Số 1 - Trang 33-43 - 2023
E Büscher1, Christian Grohé2
1Universitätsmedizin Essen – Ruhrlandklinik
2Klinik für Pneumologie, Evangelische Lungenklinik Berlin, Berlin, Deutschland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Skowasch D et al (2020) Diagnostik und Therapie der kardialen Sarkoidose. Pneumologie 74(01):24–34

Kreuter M et al (2016) Seltene Lungenerkrankungen. Springer, Berlin Heidelberg

Scharkoff T (1993) Epidemiology of sarcoidosis. Pneumologie 47(10):588–592

Baughman RP et al (2001) Clinical characteristics of patients in a case control study of Sarcoidosis. Am J Respir Crit Care Med 164(10):1885–1889

Tavora F et al (2009) Comparison of necropsy findings in patients with Sarcoidosis dying suddenly from cardiac Sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104(4):571–577

Swigris JJ et al (2011) Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 183(11):1524–1530

Sekiguchi M et al (1980) Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 44(4):249–263

Bonella F, Culver DA, Israël-Biet D (2022) Sarcoidosis Bd. 96. European Respiratory Society

Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4(3):303–309

Nery PB et al (2014) Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electro 37(3):364–374

Tung R et al (2015) Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart Rhythm 12(12):2488–2498

Marcus FI, Zareba W (2009) The electrocardiogram in right ventricular cardiomyopathy/dysplasia. How can the electrocardiogram assist in understanding the pathologic and functional changes of the heart in this disease? J Electrocardiol 42(2):136.e1–136.e5

Kumar S et al (2015) Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 8(1):87–93

Vasaiwala SC et al (2009) Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 20(5):473–476

Philips B et al (2014) Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol 7(2):230–236

Birnie DH et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11(7):1304–1323

Kouranos V et al (2017) Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac Sarcoidosis. JACC Cardiovasc Imaging 10(12):1437–1447

Mehta D et al (2008) Cardiac involvement in patients with Sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133(6):1426–1435

Schuller JL et al (2011) Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol 22(11):1243–1248

Murtagh G et al (2016) Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography 33(9):1344–1352

Orii M et al (2015) Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac Sarcoidosis: comparison with magnetic resonance imaging. J Am Soc Echocardiogr 28(6):683–691

Blessberger H, Hackl M (2018) Strain-Echokardiographie//Strain Echocardiography. J Kardiol Aust J Cardiol 25(11):343–348

Kiko T et al (2018) A multiple biomarker approach in patients with cardiac sarcoidosis. Int Heart J. https://doi.org/10.1536/ihj.17-695

Handa T et al (2010) Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 27(1):27–35

Baba Y et al (2012) Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J 53(5):287–292

Cummings KW et al (2009) A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 29(1):89–103

Hulten E et al (2016) Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysi. Circulation 9(9):e5001

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging, 2017. 18(10): p. 1073–1089.

Wicks EC et al (2018) Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J 19(7):757–767

Birnie DH et al (2016) Cardiac sarcoidosis. J Am Coll Cardiol 68(4):411–421

Bennett MK et al (2013) Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000–2009. Circ Heart Fail 6(4):676–684

Holzmann M et al (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118(17):1722–1728

Felker GM et al (1999) The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine 78(4):270–283

Frustaci A, Pieroni M, Chimenti C (2002) The role of endomyocardial biopsy in the diagnosis of cardiomyopathies. Ital Heart J 3(6):348–353

Baughman RP et al (2021) ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. https://doi.org/10.1183/13993003.04079-2020

Fazelpour S et al (2021) Corticosteroid and immunosuppressant therapy for cardiac Sarcoidosis: a systematic review. J Am Heart Assoc 10(17):e21183

Freedenberg V, Thomas SA, Friedmann E (2011) Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin 7(1):59–68

Takaya Y et al (2015) Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis. Am J Cardiol 115(4):505–509